Quebec’s provincial health authority is moving forward with what may be one of the largest consolidations of clinical laboratory testing undertaken in North America during the past 30 years. The goal is to bring the lab testing currently done in as many as 500 locations throughout the province into 11 “high-volume processing centers.” The project, called OptiLab, was announced in 2012. After several years of planning, the provincial health authority is now beginning to implement the plan. It is reported that 191 million lab tests are performed annually in the province.
MORE ON: Quebec’s Optilab
Critics of the plan to consolidate medical laboratory testing point out that as many as 70% of all test samples will need to be transported to the 11 core labs. Doris Levasser Bourbeau, President of the Professional Order of Medical Technologists of Quebec, told the Montreal Gazette that moving this volume of specimens could result in errors and lost or ruined samples. Other union leaders in the province expressed the same concern about the risk of moving such a large volume of lab specimens within the province. Proponents of the lab consolidation project have yet to point out that, for decades, large volumes of lab specimens move vast distances daily in Canada, the United States, and Australia without risk or harm to patients.
Another anatomic pathology lab company is now owned by Laboratory Corporation of America. On October 4, it was announced that Shore Capital Partners had sold Clearpath Diagnostics of Syracuse, NY, to LabCorp. Terms of the deal were not announced. It was in 2011 when Shore Capital invested in ClearPath, which has five pathologists.
- Laboratory Corporation of America has named Gene Heidt as Vice President, Corporate Strategy. Heidt has held executive positions with HealthLab at NorthwesternMedicine, Genesis Clinical Laboratory, and National Health Laboratory (before and after the merger that formed LabCorp).
- John Pouk is the new Chief Commercial Officer for 10x Genomics of Pleasanton, Calif. He formerly worked at Agilent Technologies, Stratagene, and Fisher Scientific Company.
Have you caught the latest e-briefings from DARK Daily? If so, then you’d know …
…why Strata Oncology, in tandem with Thermo Fisher, is offering 100,000 free genetic cancer tests to patients in order to match late-stage cancer patients with specific cancer drugs that might improve their recovery.
You can get the free DARK Daily e-briefings by signing up at www.darkdaily.com.
That’s all the insider intelligence for this report.
Look for the next briefing on Monday, November 7, 2016.